Objective-To analyse sex differences among recipients of benzodiazepines in Dutch general practice.
Introduction
In the Netherlands, as in the United States and the rest of Europe, some 10% of the population use tranquillisers and hypnotics. '-7 In 1989 roughly one third of Dutch patients had been taking tranquillisers or hypnotics, mostly benzodiazepines, continually for 180 days or longer and were designated long term users.3 Most long term users of benzodiazepines in the United States and Europe are elderly women. 8 13 National household surveys on the use of tranquillisers and hypnotics in the Netherlands in 1985 and 1989 disclosed that women in the age group 15-44 used these drugs at about the same low frequency (2%) as did men.67 At ages 45-64 years and 65 and over, however, 10% and 16% of the women respectively used tranquillisers or hypnotics in 1985; in the older age group this figure increased to 18% in 1989. These figures contrasted sharply with those for men; in two older age groups only 6% and 9% of men used these drugs.
Benzodiazepines are mainly prescribed by general practitioners.'415 After drugs for heart and circulatory problems benzodiazepines are the drugs most frequently prescribed by Dutch general practitioners.'6 Exact figures on the use of benzodiazepines and the reasons for prescription are not available as there is no central register of medication and consumption. Most assessments come from doctor-patient registrations, '5 health surveys,51617 pharmacy records,'8 and the Dutch national health service. '9 Recently a national survey of general practice was conducted in the Netherlands. 20 It included the complete records ofall consultations with 161 representative general practitioners and their assistants during 1 April 1987 to 31 March 1988. That study enabled us to analyse the circumstances of the initial and repeat prescriptions for benzodiazepines. Firstly, we investigated whether the figures on the use of benzodiazepines gathered from the national survey of general practice paralleled the figures from the national household surveys. Secondly, we tried to discover why doctors prescribe benzodiazepines more to women than to men.
Subjects and methods

DESIGN OF NATIONAL SURVEY OF GENERAL PRACTICE
Generalpractitioner sampling
From all 5826 general practitioners in the Netherlands on 1 Janaury 1985 a random, stratified, nonproportional sample was selected. Stratification was deemed necessary because of geographic factors contributing to morbidity data and procedures in general practice. The country was divided into three regions and four levels of urbanisation. Finally, the distance from the doctor's practice to a hospital was noted.
Comparison of the total general practitioner population in the Netherlands with the 161 doctors selected showed that 24 (15%) ofthe sample group but only 466 (8%) of all general practitioners were women. In addition, the sample group was younger and included a larger proportion of doctors in group practices.
We studied the practices of the 45 general practitioners for whom during the first three month period (1 April to 30 June 1987) details of all repeat prescriptions were recorded.
Doctor-patient contacts
Contacts with the general practitioner were recorded during consecutive three month periods of the survey year. A full registration form was used for contacts with the doctor and a shorter version of the form for contacts with the assistant to the general practitioner. No significant differences were found in regional distribution, urbanisation, or distance to the hospital between the first group of doctors (our study group) and doctors in the other three groups. Also other variables such as characteristics of the practices, numbers of episodes, reasons for consultations, sex distribution of the patients, and types of health insurance did not differ. Seasonal influences on the data were minimal.
The contact registration form included the general practitioner's identification code; the patient's identification code; the description of contact (first consultation, repeat consultation, relapse); morbidity data (reasons for consultation (reported as symptoms and diagnosis)); intervention data; and, finally, prescription data. We used records of first and repeat consultations, symptoms, diagnosis, and subsequent new or repeat prescriptions. These variables were recorded by the general practitioner and his or her assistant. For each general practitioner one fieldworker was appointed to be responsible for recording, classifying, and coding data. This centralised procedure resulted in an interobserver agreement score of 0-85 for reasons for consultation and 0-80 for rare or complicated diagnoses. The symptoms and diagnoses were classified according to the Intemational Classification of Primary Care,2 with some minor changes.22
Patient registration
The 45 general practitioners cared for a total of 61 249 patients. Their age and sex distribution did not differ significantly from that of the population as a whole. A patient registration form including information on socioeconomic status, was completed by 91% ofthe study population.
Benzodiazepine prescriptions
We selected for our study the following symptoms and diagnoses recorded in the Intemational Classification of Primary care as indications for benzodiazepine: anxiety or nervousness or feelings of inadequacy, or both; acute stress or panic disorders, or both; irritability or anger, or both; restlessness or agitation, or both; insomnia. As an additional category we studied requests for a prescription or repeat prescription. Computer analysis and statistics We evaluated prescriptions in relation to reasons for consultation (reported as symptoms and diagnoses) stratified by sex and age. The SPSS package was used to compute the risks and 95% confidence intervals. In this study the relative risk ratio is the same as the female to male relative risk ratio.
Results
AGE AND SEX DISTRIBUTION OF BENZODIAZEPINE
RECIPIENTS
The 61 249 patients in the study population comprised 29035 men and 32214 women. Analysis of the frequency of consultations with the general practitioner showed that 36047 patients (14400 male, 21 647 female) visited their general practitioner at least once during the three months.
Benzodiazepines were prescribed at least once to 4231 patients (1324 (31%) male, 2907 (69%) female). The numbers of patients prescribed benzodiazepines increased with age among both men and women (table I). In the older age groups (45-64 and 65 and over) the absolute increase was greater for women (from 12% to 20%) than for men (from 6% to 11%). Even after correcting for sex distribution in the total patient population significantly more women than men were recorded as receiving benzodiazepine prescriptions (relative risk 1-68-1-92).
When we corrected for the sex difference in visits to the general practitioner significantly more women (relative risk 1-57 for the age group 45-64 years, 1-67 for age 65 and over) than men were prescribed benzodiazepines (table II) .
INDICATIONS FOR CONTINUING BENZODIAZEPINES ASSESSED BY GENERAL PRACTITIONER
A total of 1448 (69%) male patients and 3311 (71%) female patients received a prescription for benzodiazepines on request. Because most patients' contacts with the practice entailed a request (4759 (70%)) for benzodiazepines or a repeat (6055 (89%)) prescription we decided to study to what extent general practitioners reassessed their patients' needs for repeat prescriptions.
In 90% of the men requesting benzodiazepines and 91% of the women the prescriptions were issued by the general practitioner's assistant, who referred to the diagnosis in the patient's record. These proportions were significantly higher than those in contacts with assistants that resulted in non-benzodiazepine prescriptions (data not shown).
We studied visits to the practice by benzodiazepine recipients for reasons unrelated to benzodiazepines. Most of these patients were seen by the general practitioner. No significant differences between men and women were observed.
Given that most benzodiazepine prescriptions were issued by the assistant and not by the general practitioner, the correlation among symptoms, diagnosis, and actual prescriptions was remarkably good in all age groups. No differences between men and women were observed. Between 73% and 85% of all symptoms considered indications for benzodiazepines were diagnosed as such. Also between 65% and 85% of all prescriptions for benzodiazepines were backed by a relevant diagnosis.
INITIAL BENZODIAZEPINE PRESCRIPTIONS AND SEX DIFFERENCES IN SYMPTOMS AND DIAGNOSES
As only 32% of benzodiazepine prescriptions (2166/6777) were written by the general practitioner it was difficult to study the doctor-patient interaction in long term users. We therefore studied 492 incident cases-that is, prescriptions that were annotated as "new" prescriptions separately. Of these patients, 489 (99%) were seen by the general practitioner. In contrast with 79% of repeats of all benzodiazepine prescriptions that were requests (4756/6055), among the 492 incident cases only three (1%) requests for benzodiazepines were recorded. The high frequency of contacts with general practitioners allowed us to study the impact of doctor-patient interactions on new benzodiazepine prescriptions (table III) . In all age groups more men than women had symptoms classified as indications for benzodiazepines. In the age group 45-64 years the difference was 65% v 470/o. Likewise, doctors diagnosed more in men than in women a condition requiring benzodiazepines, particularly at ages 45-64 years.
We also compared diagnoses based on symptoms considered to be indications for benzodiazepines with diagnoses made without symptoms (table IV). In the youngest age group (19-44 years) and in the oldest age group (65 and over) about half of the diagnoses were made in patients without relevant symptoms. No significant differences were observed between men and women. In the age group 45-64 years diagnoses warranting benzodiazepines were made less frequently in women. This difference did not, however, reach statistical significance. Surprisingly, benzodiazepines were prescribed to men for headache, general malaise and fatigue, chest pain, and sensory disturbances and to women for general malaise and fatigue, vertigo, depression and headache, and chest pain. Table V shows the frequency with which doctors prescribed benzodiazepines when no symptoms were identified or a diagnosis made warranting the treatment. A significant difference was observed in the age group 45-64. Women in this group received benzodiazepines without indication almost twice as often as men-45% of women (43/96) v 24% of men (15/63) .
In men of all age groups the most frequent symptoms were back pain, accident trauma, headache, sensory disturbances, and non-specified pain. The most frequent diagnoses in men were lumbago, alcohol misuse, myalgia, problems at work, and problems resulting from the death of a family member (other than a child or partner). In women the most frequent symptoms were headache, chest pain, general malaise and fatigue, abdominal pain, palpitations, back pain, and diarrhoea. The most frequent diagnoses in women were headache, hypertension, family problems, back pain, myalgia, cystitis, and problems resulting from the death of a partner. Though lumbago and back pain might be considered legitimate reasons to prescribe benzodiazepines, we did not include these symptoms or diagnoses in our study; muscle relaxation is not mentioned in efficacy studies as an indication for the drug. When women with back pain (9/315; 3%) and men with lumbago (18/177; 10%) were excluded the difference between women and men was even greater-132 (42%) of the women and 25 (14%) of the men received benzodiazepines without having relevant symptoms or diagnoses.
Discussion
Our general practice survey, confirming the results of other studies, showed that women are more often prescribed benzodiazepines than men.2223 The results of our analysis agree exactly with the results of the Dutch national household surveys, in which respondents reported their use of benzodiazepines.00 In all age groups, but particularly in the older age groups far more women received benzodiazepines than did men. This was true even after correction for the female to male ratios in the general practice as a whole. The female to male ratios of all ages were consistently higher than among the total patient population under study. This strongly indicates that there are specific causes for the greater numbers of female benzodiazepine users in Dutch general practices. In our study the greater number of women receiving benzodiazepine prescriptions is not explained by overdiagnosis of benzodiazepine indications in women. Analysis of the indications recorded for benzodiazepines showed that most were simply requests for a first or repeat prescription. From the absence of sex differences in indications for repeat prescriptions we tentatively conclude that the diagnostic process leading to the continuation of benzodiazepine use does not explain the greater proportion of women prescribed these drugs.
General practitioners generally do not see patients when they request a prescription for benzodiazepines but see these patients when they have symptoms or disorders for which other treatments would be used.
That diagnoses preceding a repeat prescription are mainly registered by the general practitioner's assistant suggests that general practitioners rarely re-evaluate their patients' continuing need for benzodiazepines. Dutch Three steps could be taken that might reduce the excessive prescribing of benzodiazepines to women. Strict criteria should be set for prescribing benzodiazepines initially. Conditions other than anxiety, stress, and insomnia should be excluded as indications for the drug. And requests for repeat prescriptions of benzodiazepines should be thoroughly re-evaluated by the general practitioner.
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(Accepted 26 May 1993) A MEMORABLE PATIENT Just a bullet in the heart He was in his mid-70s and had been admitted with a ruptured Achilles tendon. He had jumped down from a hedge on his farm, heard a loud crack, and thought he had broken his leg. His injury required a surgical repair. His preoperative chest x ray examination showed an elongated opaque foreign body in the left cardiac area. Screening showed that this moved during cardiac contraction.
"Did you know," I said, "that you have a bullet in your heart?" "Yes," said he, "it is a German 300 and it has been with me for 50 years. In fact," he continued, "I should have died on three occasions."
He had graduated from Aberystwyth University College in June 1914 and in August he joined the army and was posted to an infantry battalion. He was at the Western Front in October of that year and was out on patrol when he was shot in the chest. He thought then that he would die. He lay there for some time until a German patrol came across him. He remembered clearly a German soldier swearing at him and lifting his rifle to shoot him again, when mercifully a German officer appeared and with a pistol in his hand ordered the soldier to stop and to get a stretcher.
Some two weeks later he was in a German military hospital when the surgeon there, whom he thought was Sauerbruch, told him that he had a bullet in his heart and he proposed to remove it by open operation. Sauerbruch was one of the most eminent surgeons in the world, particularly in experimental surgery of the thorax. Nevertheless, our hero adamantly refused an operation. This was the third time, he thinks, he would have died.
He recovered from his wounds and spent the rest of the war as a prisoner. Subsequently he had a distinguished career as a chief inspector of schools. On retirement he took up farming in south Pembrokeshire. When he died many years later he left his farms and his personal fortune to the University College of Wales, Aberystwyth.-R L REES is a retired orthopaedic surgeon in Dyfed
